CapyFin

Calendar Reports Pricing

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Pharming Group NV Fiscal Q4 2025 Earnings Report | CapyFin

Pharming Group NV

PHAR · Euronext Amsterdam🇳🇱

Overview Earnings

Dividends Seasonality Metrics

Q4 2025 in 2d Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021

Mar 12

Pharming Group NV Q4 2025 Earnings Report

Estimated Revenue:$95.8M

+24.9% YoY

Estimated EPS:$0.07

+600.0% YoY

Pharming Group NV

Unlock previous datapoints

Pharming Group NV

Unlock previous datapoints

Loading...

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Pharming Group NV

Key Statistics

Market Cap

$1.12B

P/E Ratio

-6.14

Sector

N/A

Industry

N/A

52-Week High

$1.77

52-Week Low

$0.688